Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995487 | 0.87 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL11061010 | 0.87 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL7451576 | 0.84 | ALOX15 (0.47) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL5221873 | 0.83 | ALOX15 (0.33) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL16061806 | 0.81 | ALOX15 (0.37) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL16200587 | 0.81 | — | — | |
| SCHEMBL6659100 | 0.80 | ALOX15 (0.34) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL17395891 | 0.80 | ALOX15 (0.34) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL291079 | 0.80 | — | — | |
| SCHEMBL62914 | 0.80 | SLC22A6 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210115156-A1 | FC-ENGINEERED ANTI-HUMAN IGE ANTIBODIES AND METHODS OF USE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-04-22 | — | — | US | claimed |
| WO-2021064197-A1 | ISOLATED POLYPEPTIDE AND POLYPEPTIDE COMPLEXES FOR PREVENTION, ALLEVIATION AND/OR TREATMENT OF HCV INFECTIONS | Københavns Universitet (DK) | 2021-04-08 | — | — | WO | claimed |
| EP-3774925-A1 | FC-ENGINEERED ANTI-HUMAN IGE ANTIBODIES AND METHODS OF USE | Institut national de la santé et de la recherche médicale (INSERM) (FR) | 2021-02-17 | — | — | EP | claimed |
| CN-107400162-B | Homocyclic peptide Cyclo- [ (Asn)5-Cys]Preparation method of (1) | 中国工程物理研究院核物理与化学研究所 | 2020-07-21 | — | — | CN | claimed |
| EP-3236988-B1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA | INST NAT SANTE RECH MED (FR) | 2020-06-24 | — | — | EP | claimed |
| WO-2019197607-A1 | FC-ENGINEERED ANTI-HUMAN IGE ANTIBODIES AND METHODS OF USE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2019-10-17 | — | — | WO | claimed |
| EP-3498850-A1 | HETEROLOGOUS EXPRESSION CASSETTE, DNA CONSTRUCT AND VACCINE COMPOSITION FOR IMMUNIZING AGAINST FLAVIVIRUS AND/OR OTHER PATHOGENS | Fundaçâo Oswaldo Cruz (BR) | 2019-06-19 | — | — | EP | claimed |
| EP-1924281-B1 | MODIFIED INFLUENZA VIRUS FOR MONITORING AND IMPROVING VACCINE EFFICIENCY | ST JUDE CHILDRENS RES HOSPITAL (US) | 2019-05-08 | — | — | EP | claimed |
| CN-109468240-A | A kind of recombinant yeast pichia pastoris and its construction method for expressing asparagine aminopeptidase | 江南大学 | 2019-03-15 | — | — | CN | claimed |
| EP-2585094-B1 | FLAGELLIN POLYPEPTIDE AS TLR5 AGONIST FOR USE IN THE TREATMENT OF RESPIRATORY TRACT INFECTIONS | INST NAT SANTE RECH MED (FR) | 2018-08-01 | — | — | EP | claimed |
| EP-0942962-B1 | CHEMICALLY MODIFIED ENZYMES | GENENCOR INT (US) | 2006-12-27 | — | — | EP | claimed |
| WO-2003013234-A2 | METHOD FOR THE IN VIVO SCREENING OF THE BIOLOGICAL ACTIVITY OF AN ACETYLCHOLINESTERASE INHIBITOR COMPOUND ON ONE OR MORE CELLULAR TARGETS OTHER THAN ACETYLCHOLINESTERASE | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2003-02-20 | — | — | WO | claimed |
| EP-0906918-B1 | Process for production of insulin precursors having correctly linked cystein bridges | AVENTIS PHARMA GMBH (DE) | 2002-05-15 | — | — | EP | claimed |
| EP-0558630-B1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO CO (US) | 1998-04-08 | — | — | EP | claimed |
| EP-0558657-B1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO CO (US) | 1997-01-08 | — | — | EP | claimed |
| EP-0238304-B1 | Modified human tissue-type plasminogen activator and its preparation | GENENTECH INC (US) | 1996-06-19 | — | — | EP | claimed |
| EP-0410147-B1 | Modified VP1/P2A regions of rhinovirus systems | BOEHRINGER INGELHEIM INT (DE) | 1994-11-30 | — | — | EP | claimed |
| EP-0348814-B1 | Hybrid plasmid for producing subtilisin Carlsberg in bacillus | HENKEL KGAA (DE) | 1994-04-06 | — | — | EP | claimed |
| EP-0367463-A1 | Calcitonin gene related peptide analogues | CELLTECH LIMITED (GB) | 1990-05-09 | — | — | EP | claimed |
| WO-1990004605-A1 | CALCITONIN GENE RELATED PEPTIDE ANALOGUES | CELLTECH LIMITED (GB) | 1990-05-03 | — | — | WO | claimed |